Verano Holdings Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRNO.NE research report →
Price Chart
About the company
Verano Holdings Corp. functions as a vertically integrated, multi-state cannabis enterprise throughout the United States. Its operations span the complete cannabis supply chain, from growing and manufacturing to wholesale and direct-to-consumer sales, across a broad geographic range.
- CEO
- George Archos
- IPO
- 2021
- Employees
- 3,800
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on VRNO.NE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $617.96M
- P/E
- -1.69
- Fwd P/E
- 320.45
- PEG
- -0.06
- P/S
- 0.53
- P/B
- 0.65
- EV/EBITDA
- 5.08
- Div Yield
- 0.00%
- Gross Margin
- 45.76%
- Op Margin
- 6.45%
- Net Margin
- -30.72%
- ROE
- -35.22%
- ROIC
- 4.57%
Latest fiscal year · YoY change
- Revenue
- $835.88M-4.9%
- Gross Profit
- $428.67M-3.4%
- Op Income
- $95.39M
- Net Income
- $-262,422,816+23.2%
- EPS
- $-3.60+26.5%
- OCF Growth
- -52.1%
- FCF Growth
- -10.0%
- 52W High
- $13.30
- 52W Low
- $5.50
- 50D MA
- $7.75
- 200D MA
- $7.93
- Beta
- 1.42
- RSI (14)
- 56
- Avg Volume
- 46.05K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Verano said Q2 revenue fell year over year, but gross profit and adjusted EBITDA margins improved on efficiency gains, while management expects a stronger second half as wholesale recovers slowly and cost discipline continues.· August 7, 2025
- Q2 revenue was $202 million, gross profit was $113 million, and adjusted EBITDA was $66 million, or 33% of revenue.
- Revenue declined 9% year over year, with wholesale down 21% and retail up 3% year over year.
- Gross margin was 56%, helped by cultivation and production efficiencies plus a lower wholesale mix.
- Management expects to keep a historical 30% adjusted EBITDA margin profile in the back half of 2025.
- Cash use was driven by taxes and debt reduction, while CapEx remained modest at $10 million for the quarter.
Second-quarter revenue was $202 million, down 4% sequentially and 9% year over year. Gross profit was $113 million, or 56% of revenue, up 13% sequentially and in line with last year, and adjusted EBITDA was $66 million, or 33% of revenue, down 6% year over year and up 7% sequentially. Retail revenue was $169 million, up 3% year over year and flat sequentially, while wholesale revenue was $73 million, down 8% sequentially and 21% year over year, excluding intersegment eliminations. SG&A was $86 million, compared with $87 million a year ago, and net loss was $19 million. For the rest of 2025, management expects a modest improvement in wholesale in the back half, CapEx of $30 million to $45 million for the full year, and adjusted EBITDA margin to remain around the historical 30% range.
George Archos framed the quarter as progress on the company’s foundation for a stronger second half, emphasizing efficiencies, product innovation, automation and differentiation. He said the wholesale pullback was intentional to collect receivables and work only with creditworthy customers, with a slow ramp expected in the back half of the year and into 2026. He also highlighted new product launches, dispensary openings, and optimism around Virginia, Pennsylvania, Florida and broader industry catalysts like rescheduling.
Rich Tarapchak emphasized that gross profit improved because of cultivation and production efficiencies that drove better volume and yields, while SG&A stayed essentially flat at $86 million. He said net outstanding receivables have been reduced by about $9 million year to date through payment solutions, CapEx was $10 million in the quarter, and full-year CapEx is still expected to be $30 million to $45 million. On liquidity, he said the company ended Q2 with $69 million in cash and cash equivalents, generated $11 million of operating cash flow, paid $26 million in income taxes, and made $16 million in debt payments, including an early prepayment that saved about $4 million; he also said cash should build in the back half and that refinancing discussions are underway ahead of the October 2026 term loan maturity.
Analysts focused heavily on wholesale weakness, asking when it might bottom and whether inventory and sell-through could recover quickly. Management said the slowdown is deliberate, with accounts being turned back on slowly and a ‘nice slow ramp-up’ expected in the back half of 2025 and into 2026, while inventory has been sized accordingly. Questions also centered on gross margin sustainability, where management said margins should normalize to the historical 30% range, and on refinancing, where Verano said it is proactive and believes its real estate ownership supports options. In Virginia, management reiterated strong confidence in adult-use prospects and said the asset has room for future organic growth with minimal CapEx.
The bull case from the call is that Verano believes it has already done the hard work to improve quality of earnings: receivables are being managed more tightly, costs are better controlled, and the company is seeing measurable efficiency gains in cultivation and retail operations. Management expects wholesale to improve gradually, margins to stay near a historical 30% adjusted EBITDA profile, and cash to build later in the year.
The main bear case is that total revenue still declined 9% year over year, wholesale was down 21%, and management admitted the AR strategy is intentionally suppressing sales in the near term. New store openings and price compression in markets like Illinois and New Jersey are still creating pressure, and the company is relying on a gradual recovery rather than a quick rebound. There is also refinancing risk ahead of the October 2026 term loan maturity, even though management sounded constructive on its options.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.8%
- Shares Outstanding
- 73.92M
- Float Shares
- 65.65M
Our VRNO.NE coverage
Recent articles, reports, and earnings notes.
No research on VRNO.NE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRNO.NE report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.